iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with KEYTRUDA®

NEXT STORY
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
PREV STORY
PM360 2019 Innovative Company Human Care Systems
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer

author_avatar
NASDAQ Market News

Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting

CALGARY, Alberta and SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. ...

author_avatar
NASDAQ Market News

Global $35.69 Billion Blood Collection, Processing, Management Devices & Consumables Market 2017 – Forecast To 2023

Dublin, March 08, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News